scispace - formally typeset
S

Srinivasulu Aitipamula

Researcher at Agency for Science, Technology and Research

Publications -  63
Citations -  2822

Srinivasulu Aitipamula is an academic researcher from Agency for Science, Technology and Research. The author has contributed to research in topics: Cocrystal & Hydrogen bond. The author has an hindex of 25, co-authored 62 publications receiving 2405 citations. Previous affiliations of Srinivasulu Aitipamula include Polish Academy of Sciences & University of Hyderabad.

Papers
More filters
Journal ArticleDOI

Polymorphs, Salts, and Cocrystals: What’s in a Name?

TL;DR: A discussion of the FDA guidance on regulatory classification of pharmaceutical cocrystals of active pharmaceutical ingredients (APIs) was held in Manesar near Delhi, India, from February 2-4, 2012 as mentioned in this paper.
Journal ArticleDOI

Polymorphism in cocrystals: a review and assessment of its significance

TL;DR: A survey of polymorphic cocrystals can be found in this paper, where the different types of polymorphs, namely synthon, conformational, packing, and tautomeric, are identified and discussed with representative examples.
Journal ArticleDOI

Trimorphs of a pharmaceutical cocrystal involving two active pharmaceutical ingredients: potential relevance to combination drugs

TL;DR: The first example of a trimorphic cocrystal involving two active pharmaceutical ingredients (APIs), ethenzamide and gentisic acid, was reported in this paper, and metastable polymorphs convert to the stable form upon solid-state grinding.
Journal ArticleDOI

Polymorphs and Solvates of a Cocrystal Involving an Analgesic Drug, Ethenzamide, and 3,5-Dinitrobenzoic Acid

TL;DR: A 1:1 cocrystal involving an analgesic drug, ethenzamide (EA), and 3,5-dinitrobenzoic acid exists in two polymorphs and forms a series of solvates.
Journal ArticleDOI

Novel solid forms of the anti-tuberculosis drug, Isoniazid: ternary and polymorphic cocrystals

TL;DR: In this article, ternary cocrystals of an anti-tuberculosis drug, Isoniazid (INH), with pharmaceutically acceptable coformers such as nicotinamide (NA), 4-hydroxybenzoic acid (HBA), fumaric acid, and succinic acid (SA) are reported.